Cumming A D, Jeffrey S, Lambie A T, Robson J S
Medical Renal Unit, Royal Infirmary, Edinburgh, UK.
Nephron. 1989;51(2):185-91. doi: 10.1159/000185283.
We previously found that virtually all patients with nephrotic syndrome (NS) excrete supranormal amounts of urinary kallikrein; it is known that activity of the renin-angiotensin system (RAS) is increased in some such patients. We therefore studied the relationship between urinary kallikrein excretion (UKa) and plasma renin activity (PRA) in 16 patients with NS. Compared with healthy controls, PRA was normal in 8 subjects and elevated in 8; UKa was elevated in the high-renin group (40.4 +/- 5.2 nkat/24 h, normals 12.0 +/- 1.1). UKa was also elevated in the normal renin group (25.7 +/- 2.4 nkat/24 h) but to a significantly lesser degree. Significant activity in plasma against a specific substrate of glandular and renal kallikreins was observed in 8 of 10 patients with NS. Such activity was not found in plasma of 17 patients with glomerulonephritis without NS, or in 10 healthy controls. The results are in keeping with previous suggestions of a functional link between the renal kallikrein-kinin system (KKS) and the RAS, but indicate that the renal KKS is activated in NS, in some cases independently of the RAS. It is possible that renal kallikrein reaches the systemic circulation in some patients with NS.
我们先前发现,几乎所有肾病综合征(NS)患者尿激肽释放酶排泄量都超过正常水平;已知部分此类患者肾素 - 血管紧张素系统(RAS)活性增强。因此,我们研究了16例NS患者尿激肽释放酶排泄量(UKa)与血浆肾素活性(PRA)之间的关系。与健康对照相比,8名受试者的PRA正常,8名受试者的PRA升高;高肾素组的UKa升高(40.4±5.2 nkat/24小时,正常人为12.0±1.1)。正常肾素组的UKa也升高(25.7±2.4 nkat/24小时),但程度明显较轻。在10例NS患者中的8例观察到血浆中针对腺体和肾脏激肽释放酶特定底物的显著活性。在17例无NS的肾小球肾炎患者血浆或10名健康对照者血浆中未发现此类活性。这些结果与先前关于肾脏激肽释放酶 - 激肽系统(KKS)与RAS之间功能联系的推测一致,但表明在NS中肾脏KKS被激活,在某些情况下独立于RAS。在一些NS患者中,肾脏激肽释放酶有可能进入体循环。